Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Crescita Therapeutics Inc (CTX.TO)

Crescita Therapeutics Inc (CTX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Crescita Therapeutics Inc 2805, Place Louis-R-Renaud Laval QC H7V 0A3 CAN

https://www.crescitatherapeutics.com P: 450-680-4722

Description:

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue from Commercial Skincare Product Sales in Canada.

Key Statistics

Overview:

Market Capitalization, $K 8,501
Shares Outstanding, K 19,541
Annual Sales, $ 17,522 K
Annual Net Income, $ -1,986 K
Last Quarter Sales, $ 4,725 K
Last Quarter Net Income, $ -150 K
60-Month Beta 0.64
% of Institutional Shareholders 0.81%

Growth:

1-Year Return -33.08%
3-Year Return -46.30%
5-Year Return -42.00%
5-Year Revenue Growth 1.05%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.10
EPS Growth vs. Prev Year -286.64%
Dividend Payout Ratio 0.00%

CTX.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -9.95%
Return-on-Assets % -7.48%
Profit Margin % -11.33%
Debt/Equity 0.04
Price/Sales 0.50
Price/Book 0.45
Book Value/Share 0.96
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar